Revolutionary treatment allows patients get their breath back
CHANNEL NINE NATIONAL NEWS A revolutionary emphysema treatment is now on offer, enabling doctors to treat patients with a non-surgical procedure that…
Pulmonx Announces First Comprehensive Report of Collateral Ventilation Assessed by the Chartis Endobronchial Catheter in Late Stage Emphysema
Pulmonx Products Highlighted in Multiple Presentations at ATS 2014
May 19, 2014, Redwood City, California – Pulmonx, an emerging leader in interventional pulmonology, announced today that multiple clinical abstracts examining the diagnostic and therapeutic utility of its Chartis Pulmonary…
Pulmonx Endobronchial Valve (EBV) Therapy Demonstrates Safety and Significant Long-Term Benefit in French Study
April 24, 2014, Neuchâtel, Switzerland – Pulmonx, an emerging leader in interventional pulmonology, announced today that its Zephyr® Endobronchial Valve (EBV) was featured at the 18th World Congress for Bronchology and Interventional Pulmonology (WCBIP) in Kyoto, Japan in the poster presentation…
ERS interactive learning module on endoscopic lung volume reduction
This interactive case-based module illustrates the endoscopic treatment of severe emphysema by implantation of one-way-valves; emphasizes that an accurate patient selection is crucial for good outcome following ELVR; underlining that – despite of low morbidity and mortality – a strict monitoring of…
Pulmonx has launched its J-shaped endobronchial delivery catheter
The J-catheter is designed to assist in the placement of valves in difficult anatomy. Its preformed distal curvature may improve distal bronchoscope articulation by a minimum of 25% compared with the standard EDC, enabling access to difficult or tortuous anatomy
Pulmonx Announces Research Highlighting Successful Treatment of “High Risk” Patients and Improvements in Long Term Survival
September 9, 2013, Barcelona, Spain – Pulmonx, an emerging leader in interventional pulmonology, announced that its endobronchial valve (EBV) therapy is a topic of eight different scientific presentations throughout the course of the European Respiratory Society Annual Congress.
Pulmonx Introduces Latest Product Offerings at 2013 European Respiratory Society Annual Congress
September 9, 2013, Barcelona, Spain – Pulmonx, an emerging leader in interventional pulmonology, is unveiling two new products at the 23rd Annual Congress of the ERS.
Pulmonx Launches Zephyr® 4.0 Low Profile Endobronchial Valve
July 19, 2013, Neuchatel, Switzerland – Pulmonx, an emerging leader in interventional pulmonology, today announced the launch of the Zephyr® 4.0 Low Profile Endobronchial Valve (4.0-LP).
Pulmonx to Market Zephyr® EBV Therapy for Patients with “Genetic” Emphysema
August 29, 2012, Peseux, Switzerland – Pulmonx, an emerging leader in interventional pulmonology, announced today that its European notified body has granted CE approval for revised labeling of its Zephyr® Endobronchial Valve (EBV).
Pulmonx Gets FDA Nod for U.S. Trial of Emphysema Therapy
August 27, 2012, Redwood City, CA, USA – Pulmonx, an emerging leader in interventional pulmonology, announced today that the U.S. Food and Drug Administration (FDA) has approved its request for an Investigational Device Exemption (IDE) to commence a multi-center pivotal clinical trial.